Infectious Diseases - Monkeypox; What is It and How Do We Treat It?
Can't see this email? View it online
   
  Infectious Diseases  
  The latest infectious diseases news from News Medical  
 

Recombinant Omicron BA.5, BA.4 Antigens Recombinant Omicron BA.5, BA.4 Antigens

Omicron BA.4 and BA.5 sub-lineages are increasing in many countries. They are more contagious versions of the virus compared to previous Omicron variants. Sino Biological has developed a panel of recombinant RBD/Spike and nucleocapsid protein variants which can be used to evaluate the efficacy of the antibodies and vaccination.

Browse the Full Range
 
   Monkeypox; What is It and How Do We Treat It?Monkeypox; What is It and How Do We Treat It?
 
Monkeypox virus is a zoonotic Orthopoxvirus and a possible biothreat agent that causes human disease with varying morbidity and mortality.
 
   Cholera variants need to be monitored closely to prevent outbreaks, scientists urgeCholera variants need to be monitored closely to prevent outbreaks, scientists urge
 
Cholera variants are constantly evolving and need to be monitored closely to prevent outbreaks, say researchers.
 
 How prepared are we for a widespread monkeypox outbreak?
 
How prepared are we for a widespread monkeypox outbreak?In a new study, researchers summarized the epidemiology, etiology, clinical presentation, diagnosis and prevention and treatment strategies for monkeypox (MPX) caused by the monkeypox virus (MPXV).
 
 
 What is the prevalence of orthopoxviruses across different populations?
 
What is the prevalence of orthopoxviruses across different populations?In a new study, researchers assessed the prevalence of orthopoxviruses among the general populations of Bolivia, France, Laos, and Mali.
 
 
 The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines
 
The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccinesResearchers compared the durability of vaccine-induced immunity and natural infection against COVID-19.
 
 
 Sex matters when it comes to immune responses to vaccines and viral infections
 
Sex matters when it comes to immune responses to vaccines and viral infectionsA review published in Frontiers in Aging analyzed the sex differences in the safety, effectiveness, and immunogenicity of influenza and COVID-19 vaccines in older individuals. It also analyzed the way sex brings about the modification of the impact of age-related factors on vaccination.